Urogen Pharma Ltd is a biotechnology company focused on developing and commercializing innovative therapies for treating uro-oncological diseases
The company specializes in the research and development of novel drug formulations that target bladder cancer and other urological conditions, aiming to address significant unmet medical needs. With a commitment to advancing patient care, Urogen leverages its proprietary technology platforms to create transformative treatment options that enhance patient outcomes and improve the quality of life for individuals affected by these serious conditions.
Two months after Hamas attacks, US President Biden, UNSC & King of Jordan call for ceasefire. Israeli stocks rise, US envoy to UN against ceasefire. Investigations into civilian casualties & use of phosphorus munitions. UNSC to convene tomorrow.
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.
Gainers PhenomeX Inc. (NASDAQCELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
